Yadanzioside M is primarily studied for its potential biological activities, particularly in the field of anti-cancer research. It has demonstrated cytotoxic effects against certain tumor cell lines, suggesting possible use in the development of chemotherapeutic agents. Its mechanism may involve the induction of apoptosis and interference with cell cycle progression in cancer cells. Additionally, it has been investigated for its anti-inflammatory and immunomodulatory properties, which could support its application in treating chronic inflammatory conditions. Due to its natural origin and structural complexity, it also serves as a lead compound for the synthesis of derivatives with enhanced bioactivity and stability. Research remains mostly preclinical, focusing on in vitro and animal models.